Efficacy and Safety of Chiauranib in Advanced Hepatocellular Carcinoma: a Single-arm, Open-label, Multi-center, Exploratory Phase Ib Study
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2018
At a glance
- Drugs Chiauranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Chipscreen Biosciences
- 23 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Feb 2018.
- 21 Nov 2017 Planned initiation date changed from 1 Sep 2017 to 1 Dec 2017.
- 14 Aug 2017 New trial record